Navigation Links
Women & Infants participating in national research study of new fertility drug
Date:12/10/2010

The emotional and physical demands on a couple seeking fertility treatment can be daunting. Researchers are constantly on a quest to improve fertility to increase a couple's chances of becoming pregnant in the most time and cost efficient manner.

Women & Infants Hospital is one of the centers participating in a national, randomized study to investigate the efficacy of a new fertility drug. This new drug would require one weekly injection rather than daily injections to simulate ovaries to make follicles. Women between the ages of 35 and 42 may qualify for an in vitro fertilization (IVF) cycle at no cost with the investigational drug.

Lead investigator is Bala Bhagavath, MD, a reproductive endocrinologist in the Center for Reproduction and Infertility at Women & Infants Hospital and assistant professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University.

"Traditional infertility treatment requires the use of a drug that is administered through daily injections to stimulate the ovaries to produce eggs," said Dr. Bhagavath. "This new drug would require a single injection that lasts seven days. This is obviously much easier for the patient, and we're hoping it will be equally, if not more, effective than the current drugs available. "


'/>"/>

Contact: Amy Blustein
ablustein@wihri.org
401-681-2822
Women & Infants Hospital
Source:Eurekalert

Page: 1

Related medicine news :

1. Buprenorphine is better than methadone for opioid dependence in pregnant women, study shows
2. Both High, Low Levels of Vitamin D in Older Women May Be Problematic
3. U.S. Failing to Meet Goals for Womens Health: Report
4. Certain Breast Cancer Drugs Linked With Heart Risks in Older Women
5. Only Half of Women Over 40 Get Annual Mammograms
6. Low and high vitamin D levels in older women associated with increased likelihood of frailty
7. Stress and neck pain more common in women than men
8. Depression Screening Urged for Young Women With Menopause-Like Symptoms
9. Suicide rate among young women veterans more than twice that of civilians
10. Tummy Fat May Threaten Womens Bones
11. Women and Infants physician authors chapter in reference book
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Hamden, CT (PRWEB) , ... December 07, 2016 , ... ... has prompted an outpouring of comments on social media that offer a rare glimpse ... adult psychiatrist, leading ADHD authority and New York Times bestselling author, has described people ...
(Date:12/7/2016)... ... 2016 , ... They are musicians and librarians, fashion designers and fitness instructors, ... New England and around the nation. What do they have in common? All have ... beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International Airport ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... is now promoting to the US market its advanced highly customizable contact technology ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range of ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... consultation services to residents in the Sacramento/Folsom region, is initiating a charity event ... , The Another Choice Another Chance treatment center in Sacramento works to provide ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... VILLAGE, Calif. , Dec. 6, 2016 ... privately held, clinical-stage medical dermatology and aesthetics ... plc, a privately held specialty pharmaceutical company ... common inflammatory skin conditions, including psoriasis, atopic ... of the agreement, Sienna will make an ...
(Date:12/6/2016)... , Dec. 6, 2016  Arcturus Therapeutics, Inc. ... company, announced today that it entered into collaboration ... therapeutics for the treatment of NASH and other ... delivery platform LUNAR™ and UNA Oligomer chemistry. The ... Takeda,s long-standing commitment to and expertise in GI ...
(Date:12/6/2016)... , Dec. 6, 2016  Regulus Therapeutics Inc. ... leading the discovery and development of innovative medicines ... candidates at its R&D day, held in ... RGLS5040, is an anti-miR targeting microRNA-27 (miR-27) for ... RGLS4326, is an anti-miR targeting microRNA-17 (miR-17) for ...
Breaking Medicine Technology: